Explaining sex differences in adipose insulin resistance
Heightened insulin resistance in obese men may elucidate the higher prevalence of type 2 diabetes among these individuals.
List view / Grid view
Heightened insulin resistance in obese men may elucidate the higher prevalence of type 2 diabetes among these individuals.
AptaFluor SAH: A Homogenous, Universal Assay for Histone, RNA, & DNA Methyltransferases. Case Study for PRMT5, MLL4, METTL3/14, & NSP14
Stefanie Flückiger-Mangual, Chief Executive Officer, is one of TOLREMO’s scientific founders and an expert in drug resistance in cancer therapy. She is a biomedical scientist and biochemist by training (University of Fribourg and ETH Zurich, Switzerland) and holds a PhD in Molecular and Translational Biomedicine from ETH Zurich. She led…
Researchers discovered that measuring the concentrations of IL-18 in an individual’s blood could estimate future risk of stroke.
Elevated levels of trimethylamine N-oxide levels were a stronger indicator of CKD risk than the well-known risk factors.
Thousands of bile acids have been discovered, providing new insights into how microbes influence distant organ systems.
Tune in to this episode where we discuss the opportunities CRISPR/Cas technology offers to revolutionise drug discovery.
A new study provides more clarity about the immune events surrounding the onset of T1D, including a new mechanism that could be used for β-cell protection.
Researchers have discovered a new pathway which seems to be a significant contributor to the development of cardiovascular disease.
Single-cell RNA analysis provides an immunological explanation for the association between periodontitis and diabetes mellitus.
This guide provides technical background on concepts and techniques for use of Transcreener biochemical assays to measure drug-target residence times.
Researchers found that resolvinT4 restores protective macrophage biological activities in rheumatoid arthritis patients.
A deep learning model developed using circulating cell-free DNA outperformed traditional screening methods for gestational diabetes mellitus.
In this Q&A, Keith Murphy, CEO of Organovo, discusses how the shift from animal models to 3D human tissues can transform the preclinical space. Among his many insights, he details the limitations of animal models, how Organovo’s 3D human tissue models facilitate a deeper understanding of genetic expression within specific…
A new study has identified targets to refine diagnostic tests, track disease progression, and discover more effective therapies.